Frankfurt
30.10.26 | 08:01
0,009 Euro
-2,20 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.10. | Acarix AB: Acarix Provides Update on RHTP and Saudi Arabia Regulatory Process | 265 | GlobeNewswire (Europe) | Acarix has received several inquiries from shareholders regarding the status of the U.S. Rural Health Transformation Program (RHTP) and regulatory approval in the Kingdom of Saudi Arabia (KSA) and would... ► Artikel lesen | |
| 11.09. | Acarix AB: Peer-Reviewed Study Confirms CADScor System Can Diagnose Heart Failure With Far Fewer False Positives Than Standard Blood Test | 448 | GlobeNewswire (Europe) | Aalborg University-led research, published in PLOS Digital Health, found the CADScor System's acoustic sensing platform identified heart failure with diagnostic accuracy comparable to a leading blood... ► Artikel lesen | |
| 13.08. | Acarix AB Q2 Sales Increase | 10 | RTTNews | ||
| 13.08. | Earnings Call: Acarix meldet starkes Wachstum für Q2 2026, doch die Aktie gibt nach | 10 | Investing.com Deutsch | ||
| ACARIX Aktie jetzt für 0€ handeln | |||||
| 13.08. | Acarix Q2 2026 slides: US revenue surges 212%, losses narrow | 5 | Investing.com | ||
| 13.08. | Acarix Q2 2026 slides: revenue doubles as US growth accelerates | 1 | Investing.com | ||
| 13.08. | Acarix AB: Acarix Publishes Second Quarter and First Half 2026 Results | 244 | GlobeNewswire (Europe) | Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its interim financial results for the second quarter and first half 2026. The report highlights continued commercial... ► Artikel lesen | |
| 17.06. | Acarix AB: Announcement from the annual general meeting in Acarix AB | 315 | GlobeNewswire (Europe) | The annual general meeting 2026 (the "AGM") of Acarix AB ("Acarix" or the "Company") was held today on 17 June 2026 and the following resolutions were passed by the meeting.
Adoption of the income statement... ► Artikel lesen | |
| 18.05. | Earnings Call: Acarix verzeichnet starkes US-Wachstum im ersten Quartal 2026 | 2 | Investing.com Deutsch | ||
| 18.05. | Acarix AB: Acarix Publishes Interim Report, January - March 2026 | 346 | GlobeNewswire (Europe) | Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its interim financial results for the first quarter of 2026. The report highlights meaningful progress across the... ► Artikel lesen | |
| 12.02. | Acarix AB: Acarix Publishes Year-End Report 2025 | 329 | GlobeNewswire (Europe) | Malmö, Sweden - Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its 2025 year-end financial results. "Last year was a year of meaningful commercial and operational... ► Artikel lesen | |
| 11.02. | Acarix AB: Acarix Announces New Distribution Partner in Saudi Arabia for the CADScor System | 546 | GlobeNewswire (Europe) | Malmö, Sweden - Acarix AB (Nasdaq Stockholm: ACARIX), a medical device company advancing noninvasive, AI enabled diagnostics for coronary artery disease, today announced that it has entered into a strategic... ► Artikel lesen | |
| 04.02. | Acarix AB: Acarix Receives EU MDR Certification for the CADScorSystem | 439 | GlobeNewswire (Europe) | Malmö, Sweden - Acarix, a global leader in AI- and acoustics-based cardiac diagnostics, today announced that its CADScor System has successfully achieved certification under the European Union Medical... ► Artikel lesen | |
| 06.11.25 | Acarix AB: Acarix Publishes Interim Report, Third quarter 2025 | 316 | GlobeNewswire (Europe) | Malmö, Sweden - Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today announced its interim financial results for the third quarter of 2025. The report highlights international... ► Artikel lesen |
14 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 40,920 | -1,33 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat FMC auf "Underweight" mit einem Kursziel von 32,30 Euro belassen. Entgegen seinen Erwartungen seien die Konsensschätzungen an die Quartalszahlen... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 35,880 | +3,22 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Carl Zeiss Meditec auf "Underweight" mit einem Kursziel von 18,10 Euro belassen. Für die Quartalszahlen am 10. Dezember liege er beim Umsatz auf... ► Artikel lesen | |
| ECKERT & ZIEGLER | 13,400 | +1,36 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler Erhält GMP-Zertifizierung für Actinium-225 | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Zulassungsgenehmigung
Eckert & Ziegler Erhält GMP-Zertifizierung für Actinium-225
28.10.2026 / 14:00 CET/CEST
Für den... ► Artikel lesen | |
| UNITEDHEALTH | 367,80 | -0,27 % | UnitedHealth Group To Rally Over 29%? Here Are 10 Top Analyst Forecasts For Tuesday | ||
| HIMS & HERS HEALTH | 25,500 | -1,54 % | Eli Lilly hängt Novo Nordisk und Hims & Hers ab: Rekordhoch entscheidet | ||
| BICO GROUP | 2,230 | +1,59 % | Cellink mit EILMELDUNG: Folgt jetzt der nächste Kursrutsch? - Jetzt handeln, noch vor Börsenschluss! | ||
| NUGEN MEDICAL DEVICES | 0,011 | -100,00 % | NuGen Medical Devices Inc.: NuGen Announces Loan Agreement with Sol-Millennium Medical HK Limited | Toronto, Ontario--(Newsfile Corp. - September 21, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is pleased to announce the entering into of a loan agreement (the "Loan Agreement")... ► Artikel lesen | |
| SPINEWAY | 0,088 | 0,00 % | Spineway: H1 2026 results | H1 2026 results Continued growth Stable resultsStrong embedded growth driversIssuance of straight bonds to finance future growth In thousands of eurosConsolidated financial statements - UnauditedH1... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| UNIDOC HEALTH | 0,038 | +6,78 % | CSE Bulletin: Reinstatement - UniDoc Health Corp. (UDOC) | Le 7 octobre/October 2026
Effective immediately, UniDoc Health Corp. will be reinstated for trading.
The Company has rectified the default situation that gave rise to the suspension.
__________________________
En... ► Artikel lesen | |
| VERU | 2,230 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -5- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameUS75973T2006 RENALYTIX... ► Artikel lesen | |
| VIROMED MEDICAL | 4,860 | +3,40 % | EQS-Adhoc: Viromed Medical AG beschließt Kapitalerhöhung gegen Bareinlage unter Ausschluss des Bezugsrechts der Aktionäre | EQS-Ad-hoc: Viromed Medical AG / Schlagwort(e): Kapitalmaßnahmen / Kapitalerhöhung
Viromed Medical AG beschließt Kapitalerhöhung gegen Bareinlage unter Ausschluss des Bezugsrechts... ► Artikel lesen | |
| BONESUPPORT | 29,680 | +2,91 % | Bonesupport Holding AB: BONESUPPORT HOLDING AB (publ) - publishes Q3 2026 interim report | BONESUPPORT HOLDING AB (publ), a leading company in orthobiologics for the management of bone injuries, today publishes the interim report for the third quarter 2026.
"Strong growth and important progress... ► Artikel lesen | |
| CLARIANE | 3,172 | 0,00 % | Clariane 9M 2026 slides: occupancy hits 93%, €2.3bn refinancing done | ||
| SENSEONICS | 8,500 | -1,73 % | Senseonics Holdings, Inc.: Senseonics Initiates First-in-Human Study of Freedom, Designed to be the World's First CGM System with No On-body Component |
Das Unternehmen ACARIX AB kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,009 Euro und damit -2,20 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ACARIX AB finden Sie auf Wallstreet Online.